Table 6.

The differences between metastatic and nonmetastatic patients with inoperable gastric adenocarcinoma in terms of PG-SGA, GPS, and PCPS.

	Metastatic	Nonmetastatic	P value∗∗
PG-SGA∗ (%)
A	12	19
B	48	44
C	40	37	0.820
GPS# (%)
0	16	36
1	40	41
2	44	23	0.153
PCPS$ (%)
0	9	27
1	15	37
2	76	36	0.009

^∗Patient generated subjective global assessment.

^∗∗ P value was calculated based on exact Chi-square test.

^#Glasgow Prognostic Score.

^$Prealbumin/CRP based prognostic score.